Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients

Supportive Care in Cancer

Volumn 21, Issue 8, 2013, Pages 2185-2194

  Cheung, Yin Ting ^a,b   Lee, Helen Hoi Lun ^a   Chan, Alexandre ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Anxiety; Cancer; Chemotherapy; Psychosocial distress

Indexed keywords

ANTHRACYCLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CYTOTOXIC AGENT; HYPNOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL;

ADJUVANT THERAPY; ADULT; ANXIETY; ARTICLE; ASIAN; BECK ANXIETY INVENTORY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPLORATORY RESEARCH; FACTORIAL ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SYMPTOM;

EID: 84984562144     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1769-8     Document Type: Article

References (52)

1. Clarke MJ, Collins RE, Davies CE, Godwin JE, Gray RG, Peto RR (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930-942
2. So WKW, Marsh G, Ling WM et al (2010) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 14:17-22
3. Ann MS, Susan AW (2004) Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum 31:127-130
4. Burgess CC, Cornelius V, Love SB, Graham J, Richards MA, Ramirez AJ (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. Br Med J 330:702-705
5. Del Mastro L, Costantini M, Morasso G et al (2002) Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients. Eur J Cancer 38:359-366
6. Hall A, Fallowfield L (1989) Psychological outcome of treatment for early breast cancer: a review. Stress Med 5:167-175
7. Payne DK, Hoffman RG, Theodoulou M, Dosik MH, Massie MJ (1999) Screening for anxiety and depression in women with breast cancer: psychiatry and medical oncology gear up for managed care. Psychosomatics 40:64-69
8. Jones RD (2001) Depression and anxiety in oncology: the oncologist's perspective. J Clin Psychiatry 62:52-57
9. Tel H, Tel H, Doǧan S (2011) Fatigue, anxiety and depression in cancer patients. Neurol Psychiatr Brain Res 17:42-45
10. Brown LF, Kroenke KK (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50:440-447
11. Jansen CE, Cooper BA, Dodd MJ, Miaskowski C (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647-1656
12. Sobel DS (1995) Rethinking medicine: improving health outcomes with cost-effective psychosocial interventions. Psychosom Med 57:234-244
13. Lueboonthavatchai P (2007) Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 90:2164-2174
14. Vahdaninia M, Omidvari S, Montazeri A (2010) What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 45:355-361
15. Osborne RH, Elsworth GR, Hopper JL (2003) Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer 39:755-762
16. Hopwood P, Sumo G, Mills J, Haviland JS, Bliss JM (2010) The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast 19:84-91
17. Härtl K, Schennach R, Müller MA et al (2010) Quality of life, anxiety, and oncological factors: a follow-up study of breast cancer patients. Psychosomatics 51:112-123
18. Vodermaier A, Linden WL, MacKenzie R, Greig D, Marshall C (2011) Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer 105:1814-1817
19. Lim CC, Devi MK (2011) Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc 9:213-235
20. Cheung YT, Maung Shwe HG, Tan YP, Fan GKT, Ng RCH, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 23:2547-552
21. Montel SR (2010) Mood and anxiety disorders in breast cancer: an update. Curr Psychiatry Rev 6:56-63
22. Beck AT, Epstein NB, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897
23. Luo N, Fones CS-L, Thumboo J, Li S-C (2004) Factors incluencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res 13:557-565
24. Beck AT, Steer RA (1990) Beck Anxiety Inventory. Psychological Corporation, San Antonio
25. Beck AT, Steer RA (1993) Beck Anxiety Inventory Manual. The Psychology Corporation, San Antonio
26. Beck AT, Steer RA (1991) Relationship between the Beck anxiety inventory and the hamilton anxiety rating scale with anxious outpatients. J Anxiety Disord 5:213-223
27. Steer RA, Ranieri WF, Beck AT, Clark DA (1993) Further evidence for the validity of the Beck Anxiety Inventory with psychiatric outpatients. J Anxiety Disord 7:195-205
28. Butt ZA, Wagner LI, Beaumont JL et al (2008) Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 35:20-30
29. Hopwood P, Haviland JS, Mills J, Sumo G, Bliss JM (2007) The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast 16:241-251
30. Asnaani A, Richey JA, Dimaite R, Hinton DE, Hofmann SG (2010) A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders. J Nerv Ment Dis 198:551-555
31. Smith SM, Stinson FS, Dawson DA, Goldstein RB, Huang B, Grant BF (2006) Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 36:987-998
32. Lewis-Fernández R, Hinton DE, Laria AJ et al (2010) Culture and the anxiety disorders: recommendations for DSM-V. Depress Anxiety 27:212-229
33. Rao MR, Raghuram NV, Nagendra HR et al (2009) Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med 17:1-8
34. Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6:657-666
35. Cella DF, Kallich JD, McDermott A, Xu X (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15:979-986
36. Nissen MJ, Shapiro AC, Swenson KK (2011) Changes in weight and body composition in women receiving chemotherapy for breast cancer. Clin Breast Cancer 11:52-60
37. Helms RL, O'Hea EL, Corso M (2008) Body image issues in women with breast cancer. Psychol Health Med 13:313-325
38. Yap KY, Low XH, Chui WK, Chan A (2012) Computational prediction of State anxiety in Asian patients with cancer susceptible to chemotherapy-induced nausea and vomiting. J Clin Psychopharmacol 32: 207-217
39. Tchekmedyian NS, Kallich JD, McDermott AM, Fayers PM, Erder MH (2003) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198-203
40. Bender CM, Ergün FS, Rosenzweig MQ, Cohen SM, Sereika SM (2005) Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28:219-225
41. Fan G, Filipczak L, Chow E (2007) Symptom clusters in cancer patients: a review of the literature. Curr Oncol 14:173-179
42. Curt GA, Breitbart WSD, Cella DF et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist 5:353-360
43. Möhler H (2012) The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 62:42-53
44. Bourin MS, Hascoët M (2001) Drug mechanisms in anxiety. Curr Opin Investig Drugs 2:259-265
45. Ettinger AB (2006) Psychotropic effects of antiepileptic drugs. Neurol 67:1916-1925
46. Kawase E, Karasawa K, Shimotsu S et al (2012) Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. Breast cancer 19:147-152
47. Takahashi T, Hondo M, Nishimura K et al (2008) Evaluation of quality of life and psychological response in cancer patients treated with radiotherapy. Jpn J Radiol 26:396-401
48. Garssen B (2004) Psychological factors and cancer development: evidence after 30 years of research. Clin Psychol Rev 24:315-338
49. Schwarz RA, Krauß O, Höckel M, Meyer A, Zenger M, Hinz A (2008) The course of anxiety and depression in patients with breast cancer and gynaecological cancer. Breast Care 3:417-422
50. Hill J, Holcombe C, Clark L et al (2011) Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med 41:1429-1436
51. Schou IM, Ekeberg Ö, Kåresen R, Sorensen E (2008) Psychosocial intervention as a component of routine breast cancer care - Who participates and does it help? Psychooncology 17:716-720
52. Björneklett HG, Lindemalm C, Rosenblad A et al (2012) A randomised controlled trial of support group intervention after breast cancer treatment: results on anxiety and depression. Acta Oncol 51:198-207